Canada approved Amylix Pharmaceuticals Last week Inc.’s new drug for amyotrophic lateral sclerosis. Now some US patients with the deadly neurodegenerative disorder — also known as Lou Gehrig’s disease — are considering moving north to take the drug Albrioza. Medicine Not approved in US
William Woods, a 75-year-old retired doctor in Atlanta who was diagnosed with ALS in 2019, is contacting doctors in Canada who can help him get over Albrioza. “There’s a lot to understand, but I’m sure I’ll find someone I can go to see,” he said.